Entia Biosciences Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Mar '26 Mar 10, 2026	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012
Market Capitalization	0	2	3	3	5	4
Market Cap Growth	-98.48%	-39.83%	-7.81%	-40.38%	28.04%	12.37%
Enterprise Value	-	2	3	3	5	4
Last Close Price	0.00	0.06	0.09	0.20	0.60	0.50
PS Ratio	0.01	5.94	7.55	4.33	15.14	10.08
PB Ratio	0.00	-0.80	-3.31	-24.38	-5.02	-5.74
EV/Sales Ratio	-	8.01	8.00	5.23	16.50	11.21
Debt / Equity Ratio	-0.53	-0.53	-0.35	-3.73	-0.44	-0.70
Net Debt / Equity Ratio	-0.49	-0.49	-0.32	-2.87	-0.41	-0.68
Net Debt / EBITDA Ratio	-0.84	-0.84	-0.13	-0.19	-0.15	-0.42
Net Debt / FCF Ratio	-1.36	-1.36	-0.47	-0.49	-0.47	-1.34
Asset Turnover	0.60	0.60	0.53	0.87	0.57	0.85
Inventory Turnover	1.66	1.66	2.97	2.63	0.97	0.70
Quick Ratio	0.04	0.04	0.03	0.35	0.03	0.07
Current Ratio	0.11	0.11	0.10	0.44	0.14	0.22
Return on Assets (ROA)	-164.37%	-164.37%	-181.53%	-147.40%	-306.38%	-155.65%
Return on Capital Employed (ROCE)	70.10%	70.10%	242.20%	1519.60%	282.40%	167.20%
Earnings Yield	-40980.09%	-88.55%	-86.28%	-80.83%	-65.15%	-33.96%
FCF Yield	-	-45.37%	-20.79%	-24.10%	-17.19%	-8.91%
Buyback Yield / Dilution	-15.84%	-15.84%	-157.24%	-25.34%	-3.22%	-16.62%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.